Detecting CEA mRNA in Peritoneal Washes for Gastric Cancer Prognosis
Author Information
Author(s): Ito S, Nakanishi H, Kodera Y, Mochizuki Y, Tatematsu M, Yamamura Y
Primary Institution: Aichi Cancer Center Hospital, Nagoya, Japan
Hypothesis
Can quantifying carcinoembryonic antigen (CEA) mRNA in peritoneal washes predict peritoneal recurrence in gastric cancer patients?
Conclusion
Quantifying CEA mRNA in peritoneal washes is a reliable prognostic indicator of peritoneal recurrence in gastric cancer patients.
Supporting Evidence
- 20 of the 86 patients died during the study, with 13 developing peritoneal metastases.
- Positive CEA mRNA was a significant independent risk factor for both survival and peritoneal recurrence-free survival.
- Overall survival was significantly worse for patients with positive CEA mRNA.
Takeaway
This study shows that measuring a specific substance in the fluid from the belly can help doctors predict if stomach cancer will come back after surgery.
Methodology
The study involved a training set of 197 patients to determine a cutoff value for CEA mRNA, followed by a validation set of 86 patients to assess the predictive ability of this measurement.
Potential Biases
There may be risks of bias in patient selection and the interpretation of results due to the nature of the study design.
Limitations
The study may have limitations due to the exclusion of patients with certain conditions and the potential for false positives in CEA mRNA detection.
Participant Demographics
Patients were primarily gastric cancer patients who underwent curative surgery, with a mix of advanced disease stages.
Statistical Information
P-Value
p=0.0130
Confidence Interval
95% CI not provided
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website